HTLV-1 associated myelopathy/tropical spastic paraparesis
Alternate names[edit]
HAM/TSP; Human T-cell leukemia virus type 1 associated myelopathy/tropical spastic paraparesis; Tropical spastic paraparesis (formerly)
Definition[edit]
HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive disease of the nervous system that affects less than 2% of people with HTLV-1 infection.

Cause[edit]
- The cause of TSP was obscure until the mid-1980s, when an important association was established between the human retrovirus — human T-cell lymphotrophic virus type 1 (also known as HTLV-1) — and TSP.
- TSP is now called HTLV-1 associated myelopathy/ tropical spastic paraparesis or HAM/TSP.
- The HTLV-1 retrovirus is thought to cause at least 80 percent of the cases of HAM/TSP by impairing the immune system.
Signs and symptoms[edit]
Signs and symptoms of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) vary but may include:
- Slowly progressive weakness and spasticity of one or both legs
- Exaggerated reflexes (hyperreflexia)
- Stiff muscles
- Muscle contractions in the ankle (ankle clonus)
- Lower back pain
- A 'weak' bladder and/or urinary incontinence
- Minor sensory changes, especially burning or prickling sensations and loss of vibration sense
Diagnosis[edit]
Tropical spastic paraparesis can be diagnosed by using MRI (magnetic resonance imaging) and lumbar puncture (which may show lymphocytosis).
Treatment[edit]
- Treatment generally aims to control the specific symptoms, as there is no standard treatment available.
- Interferon alpha may be beneficial over short periods, and some aspects of the disease may be improved with interferon beta.
- Stiff and spastic muscles may be treated with lioresal or tizanidine, and urinary dysfunction may be treated with oxybutynin.
- Corticosteroids were reported to slow progression in one case series and reduce neurologic disability in another.
- However, others have reported no such benefit with corticosteroids and there have been no randomized clinical trials.
| Focal lesions of the spinal cord | ||||||
|---|---|---|---|---|---|---|
|
| Infectious diseases – viral systemic diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
NIH genetic and rare disease info[edit]
HTLV-1 associated myelopathy/tropical spastic paraparesis is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - HTLV-1 associated myelopathy/tropical spastic paraparesis
|
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian